News
The FDA and Stealth look set to relitigate the debate, with the biotech planning to file for approval once again. Stealth has ...
2d
InvestorsHub on MSNAscendis Pharma Rises as FDA Grants Priority Review for Achondroplasia TreatmentShares of Ascendis Pharma AS (NASDAQ:ASND) rose 5.8% after the U.S. Food and Drug Administration (FDA) accepted the company’s ...
A day after the FDA tightened the restrictions for winning vaccine approvals, Moderna Inc. is pulling its application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results